Hubei Goto Biopharm Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	85.85	141.18	181.97	438.42	209.91
Trading Asset Securities	0	0	0	15.01	0.1
Cash & Short-Term Investments	85.85	141.18	181.97	453.43	210.02
Cash Growth	-39.19%	-22.42%	-59.87%	115.90%	625.10%
Accounts Receivable	189.1	214.26	235.4	269.36	243.86
Other Receivables	3.3	2.05	2.15	1.88	2.09
Receivables	192.4	216.31	237.54	271.25	245.95
Inventory	473.76	384.8	396.16	432.5	371.24
Prepaid Expenses	-	-	-	-	1.68
Other Current Assets	18.28	27.7	54.06	56.56	29.37
Total Current Assets	770.29	770	869.73	1,214	858.26
Property, Plant & Equipment	1,883	1,849	1,391	610.94	256.57
Long-Term Investments	48.29	48.27	48.24	48.08	14.47
Other Intangible Assets	53.79	49.88	51	43.14	27.82
Long-Term Deferred Tax Assets	62.77	37.29	22.62	17.89	8.82
Long-Term Deferred Charges	6.56	9.69	13.3	13.96	0.97
Other Long-Term Assets	26.12	25.78	51.96	121.56	44.34
Total Assets	2,851	2,790	2,448	2,069	1,211
Accounts Payable	461.26	459.91	532.24	205.52	138.17
Accrued Expenses	9.64	12.43	9.25	9.58	7.51
Short-Term Debt	229.75	294.3	110.09	321.63	143.41
Current Portion of Long-Term Debt	95.35	24.55	22.27	5.24	-
Current Portion of Leases	-	0.06	0.45	1.98	11.47
Current Income Taxes Payable	0.43	0.08	2.8	7.21	11.27
Current Unearned Revenue	6.59	1.23	3.47	2.01	3.7
Other Current Liabilities	19.06	15.13	5.84	22.79	17.65
Total Current Liabilities	822.08	807.69	686.41	575.97	333.18
Long-Term Debt	974.16	812.64	652.37	437.04	-
Long-Term Leases	-	-	0.54	4.41	6.67
Long-Term Unearned Revenue	144.06	150.25	84.33	69.71	42.98
Long-Term Deferred Tax Liabilities	0.98	0.01	0.29	0.97	0
Other Long-Term Liabilities	0.02	4.65	0.03	0.05	-
Total Liabilities	1,941	1,775	1,424	1,088	382.83
Common Stock	115.28	115.28	115.28	115.28	115.28
Additional Paid-In Capital	409.02	410.6	410.77	409.11	409.11
Retained Earnings	227.41	300.77	330.2	307.2	282.67
Treasury Stock	-21.97	-	-	-	-
Comprehensive Income & Other	96.48	96.49	96.49	96.51	-
Total Common Equity	826.22	923.14	952.75	928.09	807.05
Minority Interest	83.14	91.5	71.03	53.07	21.36
Shareholders' Equity	909.36	1,015	1,024	981.16	828.42
Total Liabilities & Equity	2,851	2,790	2,448	2,069	1,211
Total Debt	1,299	1,132	785.73	770.3	161.54
Net Cash (Debt)	-1,213	-990.37	-603.75	-316.87	48.47
Net Cash Per Share	-10.59	-8.61	-5.25	-2.76	0.46
Filing Date Shares Outstanding	110.98	115.28	115.28	115.28	115.28
Total Common Shares Outstanding	110.98	115.28	115.28	115.28	115.28
Working Capital	-51.79	-37.69	183.33	637.76	525.08
Book Value Per Share	7.44	8.01	8.26	8.05	7.00
Tangible Book Value	772.43	873.26	901.75	884.95	779.23
Tangible Book Value Per Share	6.96	7.58	7.82	7.68	6.76
Buildings	-	506.33	129.73	108.67	95.53
Machinery	-	820.79	207.89	196.16	180.78
Construction In Progress	-	694.41	1,182	411.99	66.38